About this trial
To develop and measure the effects of a culturally sensitive yoga program for inpatients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;
Age 18 or older;
English, Hindi, or Swahili speaking;
Able to sign a written informed consent and be willing to follow protocol requirements.
Disqualifiers
Extreme mobility issues that preclude participating in the YT;
Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;
HCT comorbidity score of 3 or higher, excluding cancer diagnoses
Trial design
Single group
Treatments tested in this trial
Yoga Sessions
BehavioralParticipants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.
Questionnaries
BehavioralParticipants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.
Interviews
BehavioralParticipants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).
Treatment groups
Trial outcomes
Primary outcomes
Patient Health Questionnaire-8 (PHQ-8)
The PHQ-8 is a 8-item self-report questionnaire used to assess bother of depressive symptoms over the past 2 weeks. The PHQ-8 is a 8-item questionnaire to screen for degree of depressive symptoms scored on a 0-24 scale with higher scores indicating greater distress and impairment
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator